Om Produodopa
En ny måte å administrere levodopa på.
REFERANSER
1. Rosebraugh M, Voight EM, Moussa EM et al. Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. Ann Neurol. 2021 Jul;90(1):52-61
2. Produodopa SPC, avsnitt 2, 4.2, 5.1, sist godkjent 23.11.2023
3. Rosebraugh M, Sodtmann S, Liu W, Facheris MF. Foslevodopa/foscarbidopa subqutaneous infusion maintains eqvivalent levodopa exposure to levodopa. Parkin and Relat Dis 97 (2022) 68-72
NO-PRODD-230021 versjon 2.0/Januar 2024